Drug for Multiple Myeloma Demonstrated to Significantly Extend Disease-Free Survival (National Institutes of Health)

Automated News - Automated News

User Rating: / 0
PoorBest 
Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following a blood stem cell transplant had their cancer kept in check longer than patients who received a placebo.

Read more: Yahoo! News Search Results for Multiple Myeloma

Comments (0)
Only registered users can write comments!

Users Online

We have 53 guests and 0 members online
No users online.

Recent Forum Topics

 

Myeloma Forums

Facebook Image

Social Bookmark

RSS Syndicator

Feed
Feed

Search Articles

Gallery Preview



Polls

How did you find us?
 

Polls

Did you have a Stem Cell Transplant?
 

Visitors Counter

mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday620
mod_vvisit_counterYesterday1019
mod_vvisit_counterThis week5434
mod_vvisit_counterLast week6230
mod_vvisit_counterThis month2586
mod_vvisit_counterLast Month28725
mod_vvisit_counterAll234666

Online (20 minutes ago): 18
Your IP: 38.107.191.84
,
Now is: 2010-09-03 14:59
JoomlaWatch Stats 1.2.9 by Matej Koval



Copyright © 2010 Myeloma Forums. - All Rights Reserved